SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Voyager to Present VY1706 and VY7523 Posters at CTAD 2026

Voyager Therapeutics says its VY1706 gene therapy and VY7523 anti-tau antibody for Alzheimer’s disease will be featured in poster presentations at CTAD 2026.

VYGR

Related stories